Hypertension in minority populations: new guidelines and emerging concepts

Fátima Rodriguez1, Keith C Ferdinand1

  • 1Department of Cardiovascular Medicine, Stanford University, Palo Alto, CA; and Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA.

Insights

Racial and ethnic disparities in hypertension and chronic kidney disease (CKD) are influenced by social factors and emerging biological elements. Multidimensional treatment approaches are proposed for diverse US populations, including African Americans and Hispanics.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Public Health

Background:

  • Persistent disparities in hypertension, chronic kidney disease (CKD), and cardiovascular disease exist among US racial/ethnic minority groups.
  • While social determinants of health are primary mediators, emerging data suggest biological factors also contribute to these health disparities.
  • Race is a social construct, and ethnicity definitions are imprecise, yet race/ethnicity categories aid in interpreting health data and ensuring clinical trial generalizability.

Purpose of the Study:

  • To review hypertension epidemiology, pathophysiology, and management in diverse US minority populations, focusing on African Americans and Hispanics.
  • To highlight the intersection of hypertension and CKD, particularly in African Americans.
  • To propose multidimensional treatment strategies for hypertension in diverse populations.

Main Methods:

  • Literature review exploring existing data on hypertension and CKD in US racial/ethnic minority groups.
  • Analysis of the interplay between social determinants of health, potential biological factors, and health outcomes.
  • Synthesis of current understanding and proposal of integrated treatment approaches.

Main Results:

  • Hypertension and CKD disparities are significant, influenced by both social and biological factors.
  • African Americans experience a high burden of hypertension and CKD, underscoring the need for targeted research and interventions.
  • Heterogeneity exists within racial/ethnic groups, suggesting a need for nuanced approaches beyond broad categorizations.

Conclusions:

  • Addressing hypertension and CKD disparities requires understanding the complex interplay of social, biological, and genetic factors.
  • Multidimensional treatment strategies involving population, community, health system, and individual levels are essential for diverse populations.
  • Further research is needed to elucidate biological mechanisms and refine interventions for specific minority groups.

Related Concept Videos

Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.3K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
926
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
792
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.7K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
662